Nov 14 (Reuters) - Helius Medical Technologies Inc
HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES, INC. REPORTS THIRD QUARTER
2022
FINANCIAL RESULTS
* HELIUS MEDICAL TECHNOLOGIES INC - CASH ON HAND EXPECTED TO
FUND
OPERATIONS THROUGH 2023
* HELIUS MEDICAL TECHNOLOGIES INC - BASIC AND DILUTED NET
LOSS PER
SHARE FOR Q3 2022 WAS $0.12
* HELIUS MEDICAL TECHNOLOGIES INC - AS OF SEPTEMBER 30,
2022,
COMPANY HAD CASH OF $16.7 MILLION
* HELIUS MEDICAL TECHNOLOGIES INC - TOTAL Q3 REVENUE UP 80%
OVER
PRIOR YEA
Source text for Eikon: ID:nGNX5CHBmS
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))